Evidence map›Paper›PMID 3026947›Full record

ArticleHuman genetics1987

The gene encoding vasoactive intestinal peptide is located on human chromosome 6p21----6qter.

I Gozes, R Avidor, Y Yahav, D Katznelson, C M Croce, K Huebner

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2008
    Article
  3. Article
  4. Article
  5. Genetic factors in sleep disorders.Journal of neurology, neurosurgery, and psychiatry · 1989
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

I Gozes
R Avidor
Y Yahav
D Katznelson
C M Croce
K Huebner
Sheba Medical Center · ILThe Wistar Institute · USWeizmann Institute of Science · IL

Funding

VIROLOGY AND GENETICS OF CANCERP01CA021124 · NCI · WISTAR INSTITUTE · PI KOPROWSKI, HILARY · 1985 to 1999
–
GENTEICS OF HUMAN HEMATOPOIETIC NEOPLASIASR35CA039860 · NCI · WISTAR INSTITUTE · PI CROCE, CARLO M · 1985 to 1998
–
NCI NIH HHS CA-10815NCI NIH HHS CA-21124NCI NIH HHS CA-39860
6 · The paper itself

Abstract

Vasoactive intestinal peptide (VIP) is a regulatory neuropeptide involved in a wide variety of functions, among them vasodilation, smooth muscle relaxation, sweat secretion, gastrointestinal peristalsis, and pancreatic function. A deficient VIP-innervation of sweat glands was recently described as a possible pathogenic factor in sweating of cystic fibrosis (CF) patients. To investigate a possible role for a defective VIP-gene in cystic fibrosis, we have used a panel of rodent-human hybrid cells, retaining defined complements of human chromosomes to localize the VIP-gene to the human chromosome region 6p21----6qter. As the CF gene was recently mapped to chromosome 7, we conclude that the VIP-gene is not the primary gene defect in this disease.

Indexed as

Chromosome MappingChromosomes, Human, Pair 6AnimalsCystic FibrosisDNA Restriction EnzymesGenetic MarkersHumansHybrid CellsMiceVasoactive Intestinal PeptideDNA Restriction EnzymesGenetic MarkersVasoactive Intestinal Peptide

Identifiers

PMID3026947
OpenAlexW151209927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.